Photo from wikipedia
Positron emission tomography (PET) with the liver‐specific tracer [18F]‐fluoro‐2‐deoxy‐D‐galactose (18F‐FDGal) can be used for imaging of hepatocellular carcinoma (HCC). Curative intended and locoregional treatments of HCC require absence of extrahepatic… Click to show full abstract
Positron emission tomography (PET) with the liver‐specific tracer [18F]‐fluoro‐2‐deoxy‐D‐galactose (18F‐FDGal) can be used for imaging of hepatocellular carcinoma (HCC). Curative intended and locoregional treatments of HCC require absence of extrahepatic disease. The aim of this prospective study was to determine whether adding 18F‐FDGal PET/CT to standard work‐up changes the planned treatment in patients with HCC deemed suitable for curative or locoregional treatment.
Journal Title: Liver International
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!